Related references
Note: Only part of the references are listed.Cross-Talk between the Complement Pathway and the Contact Activation System of Coagulation: Activated Factor XI Neutralizes Complement Factor H
Cristina Puy et al.
JOURNAL OF IMMUNOLOGY (2021)
Solution structures of human myeloma IgG3 antibody reveal extended Fab and Fc regions relative to the other IgG subclasses
Valentina A. Spiteri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome
Vittorio Pengo et al.
BLOOD (2018)
Antiphospholipid syndrome - an update
Birgit Linnemann
VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE (2018)
Differential activation mechanisms of serum C5a in lupus nephritis and neuropsychiatric systemic lupus erythematosus
Yuko Sakuma et al.
MODERN RHEUMATOLOGY (2017)
Coagulation cascade and complement system in systemic lupus erythematosus
Yan Liang et al.
Oncotarget (2017)
Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome
Bahar Artim-Esen et al.
SCIENTIFIC REPORTS (2017)
The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation
H. Kozarcanin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism
D. R. J. Arachchillage et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial
Hannah Cohen et al.
Lancet Haematology (2016)
Complement and its role in innate and adaptive immune responses
Jason R. Dunkelberger et al.
CELL RESEARCH (2010)
Antibodies to Serine Proteases in the Antiphospholipid Syndrome
Pojen P. Chen et al.
Current Rheumatology Reports (2010)
Factor Xa: at the crossroads between coagulation and signaling in physiology and disease
Keren Borensztajn et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Generation of C5a in the absence of C3: a new complement activation pathway
Markus Huber-Lang et al.
NATURE MEDICINE (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Share Paper
